Deliang Cao

Affiliations: 
Molecular Biology Microbiology and Biochemistry Southern Illinois University at Carbondale, Carbondale, IL 
Area:
Cell Biology
Google:
"Deliang Cao"

Children

Sign in to add trainee
Amit U Joshi grad student SIU School Medicine (Neurotree)
Yiwen Bu grad student 2014 SIU Carbondale
Ashim Gupta grad student 2014 SIU Carbondale
BETA: Related publications

Publications

You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect.

Ye X, Wang T, Zhong L, et al. (2024) Aldo-keto reductase 1B10 as a Carcinogenic but Not a Prognostic Factor in Colorectal Cancer. Journal of Cancer. 15: 1657-1667
He YC, He L, Khoshaba R, et al. (2019) Curcumin Nicotinate Selectively Induces Cancer Cell Apoptosis and Cycle Arrest through a P53-Mediated Mechanism. Molecules (Basel, Switzerland). 24
Cao Z, Wu P, Su M, et al. (2019) Long non-coding RNA UASR1 promotes proliferation and migration of breast cancer cells through the AKT/mTOR pathway. Journal of Cancer. 10: 2025-2034
Rao KA, Robinson K, Delfino K, et al. (2019) Analysis of AKR1B10 levels among various groups of breast cancer patients. Journal of Clinical Oncology. 37: e14548-e14548
Wang X, Cao D. (2019) Abstract 502: Aldo-keto reductase 1B8 (AKR1B8) deficiency causes intestinal immune deficiency Cancer Research. 79: 502-502
Huang C, Cao Z, Ma J, et al. (2018) AKR1B10 Activates Diacylglycerol (DAG) Second Messenger in Breast Cancer Cells. Molecular Carcinogenesis
Cao Y, Lin M, Bu Y, et al. (2017) p53-inducible long non-coding RNA PICART1 mediates cancer cell proliferation and migration. International Journal of Oncology
Cao Y, Cao D, Ling H. (2017) The novel long non-coding RNA PANCR: A p53 activator and potential breast cancer biomarkers. Journal of Clinical Oncology. 35: e23016-e23016
Bu Y, Cai G, Shen Y, et al. (2016) Targeting NF-κB RelA/p65 Phosphorylation Overcomes RITA Resistance. Cancer Letters
Huang C, Verhulst S, Shen Y, et al. (2016) AKR1B10 promotes breast cancer metastasis through integrin α5/δ-catenin mediated FAK/Src/Rac1 signaling pathway. Oncotarget
See more...